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I. INTRODUCTION 
The first reports of topoisomerase modification were published in 1982 
and 1983 (Mills et al. 1982; Durban et al. 1983; Ferro et al. 1983; 
10ngstra-Bilen et al. 1983). Although a wide variety of posttranslational 
modifications of DNA topoisomerases may occur, this chapter focuses 
only on phosphorylation and poly(ADP-ribosylation), which have been 
observed both in vitro and in vivo. The experimental data suggest a 
regulatory role, but the precise cellular functions of these DNA 
topoisomerase modifications remain undefined at the present time. 
A. Phosphorylation of DNA Topolsomerase at Serine Residues 
The initial reports of phosphorylation in topoisomerases involved 
topoisomerase I purified from Novikoff hepatoma cells. A phosphopro-
tein of approximately 110 kD with a pI of 8.4 purified from cells labeled 
with 32p (Durban et al. 1981) was subsequently identified as DNA 
topoisomerase I (Durban et al. 1983). A fonn of topoisomerase I could 
also be labeled in vitro by incubation with serine-specific protein kinases 
and [32p]ATP. A protein kinase from an African Burkitt's lymphoma 
cell line that appeared to exhibit high affinity for topoisomerase I was 
purified (Mills et al. 1982). This serine kinase had an apparent Km of ap-
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proximately 0.3 IlM for topoisomerase I; phosphorylation stimulated the 
DNA-relaxing activity of the enzyme three- to fivefold. The discovery of 
phosphorylation of topoisomerase I was followed by reports of 
phosphorylation of topoisomerase II. Sander et al. (1984) found a protein 
kinase activity that remained associated with Drosophila topoisomerase 
II through four purification steps. Phosphoserine was the predominant 
species modified by the topoisomerase-associated protein kinase. 
Because phosphorylation and dephosphorylation of proteins are 
recognized as major mechanisms for regulating cellular functions, the 
reports of DNA topoisomerase phosphorylation stimulated studies with 
purified protein kinases. Casein kinase II, a messenger-independent 
kinase that uses acidic proteins like casein as substrate (Edelman et al. 
1987), phosphorylated Drosophila DNA topoisomerase II; two to three 
phosphates are incorporated into each topoisomerase II polypeptide chain 
(Ackerman et al. 1985, 1988). In this study, no autophosphorylation of 
topoisomerase occurred, and serine was the only amino acid residue 
modified by casein kinase II. The reaction was moderately specific, 
showing an apparent Km of 0.4 J.lM for topoisomerase II. Phosphorylation 
of the enzyme stimulated DNA relaxation activity approximately two- to 
threefold and was reversed by treatment with alkaline phosphatase. 
Even more compelling is the evidence that casein kinase II type en-
zymes phosphorylate DNA topoisomerase I. The phosphorylation of 
Novikoff topoisomerase I increases enzymatic activity (Durban et al. 
1983); the serine residue, which is the primary site of phosphorylation in 
vivo, is phosphorylated by purified casein kinase II in vitro (Durban et al. 
1985). In Xenopus ovaries, phosphorylation of DNA topoisomerase I 
may be obligatory for enzymatic activity (Kaiserman et al. 1988). DNA 
topoisomerase activity was lost when the Xenopus enzyme was treated 
with phosphatase and was regained after treatment with ATP and a 
casein-kinase-II-like activity (Fig. 1). Indeed, dephosphorylation blocked 
the topoisomerase I nicking of DNA induced by the drug camptothecin. 
Thus, phosphorylation of this enzyme appears to be required for the 
formation of the initial covalent enzyme/DNA complex. Whether this to-
tal dependence on phosphorylation for catalytic activity is a special prop-
erty of DNA topoisomerase from Xenopus ovaries or whether it is char-
acteristic of most DNA topoisomerase I enzymes remains to be estab-
lished. 
Protein kinase C and a calmodulin-dependent protein kinase also 
phosphorylated topoisomerase II in vitro (Sahyoun et al. 1986). Protein 
kinase C is a well-characterized calcium-dependent and phospholipid-
activated protein kinase. This cellular enzyme is the receptor for phorbol 
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Figure 1 Some possible covalent modifications of DNA topoisomerases in 
higher eukaryotes. (1) Unmodified topoisomerase. (2) Topoisomerase phosphor-
ylated at a serine residue. (3) Topoisomerase with both a phosphoserine and a 
poly(ADP-ribose) chain. A indicates adenine, R indicates ribose, P indicates 
phosphate. Type I and II topoisomerases can be modified by serine kinases, such 
as casein kinase II, to yield a phosphorylated enzyme as shown in structure 2. In 
many cases, this modification stimulates activity and in Xenopus oocytes 
phosphorylation of serine may be required for activity. The reversibility of 
phosphorylation has been documented in vitro but not in vivo; this reaction is 
presumably carried out by a protein phosphatase. Topoisomerases are also sub-
strates for poly(ADP-ribose) synthetase in higher eukaryotes (structure 3). The 
modification site on the protein is probably a glutamate residue, and ADP-ribose 
chains of varying lengths are added to the enzyme. The DNA breaking-joining 
activity of the modified proteins becomes progressively more inhibited as the 
chains become longer. This process is reversed by a second nuclear enzyme, 
poly(ADP-ribose) glycohydrolase, which reactivates the modified enzyme. 
Protein kinase C shows a high affinity for its topoisomerase target with 
an apparent Km for Drosophila topoisomerase II of about 100 nM. The 
reaction requires calcium and phosphatidyl serine and is stimulated by 
phorbol esters. Approximately 1 mole of phosphate is incorporated per 
mole of topoisomerase II, suggesting that a single site on the enzyme 
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might be phosphorylated. Like the studies described above with casein 
kinase II, topoisomerase phosphorylated by protein kinase C exhibited 
two- to threefold stimulation of DNA-relaxing activity. Studies of intact 
cells of the sponge Geodia cydonium are consistent with the involvement 
of protein kinase C in the phosphorylation of DNA topoisomerase II in 
vivo (Rottmann et aI. 1987). 
B. Other Phosphorylation Reactions 
Other examples of topoisomerase phosphorylation have been described 
only in vitro. These include phosphorylation at tyrosine residues and the 
automodification of prokaryotic topoisomerases with the precise site of 
phosphorylation presently undefined. 
Tyrosine protein kinase activity is intrinsic to numerous oncogene 
products and cell receptors that are implicated in modulation of cell 
growth. There are two reports of tyrosine protein kinases that can modify 
topoisomerases (Tse-Dinh et al. 1984, Goldberg et al. 1985). Rous sar-
coma virus transforming gene product pp60src phosphorylates tyrosine 
moieties on Escherichia coli topoisomerase I, Micrococcus [uteus gyrA 
subunit, calf thymus topoisomerase I, and calf thymus topoisomerase II. 
In the cases of the type-I topoisomerases of E. coli and calf thymus, 
phosphorylation of tyrosine residues is associated with loss of greater 
than 90% of the DNA-relaxing activity. This result indicates that the 
tyrosine involved in coupled DNA breakage and reunion activity may be 
a target of protein kinase modification. Similar results were obtained 
with a less well-defined 75-kD cellular protein kinase isolated from 
uninfected cells. However, since these kinases are normally membrane-
bound proteins that may not travel to the nucleus, the significance of 
these results awaits further testing. 
Prokaryotic DNA topoisomerases have autophosphorylation activity. 
Three subunits that make up the bacteriophage T4 DNA topoisomerase 
complex are encoded by products of genes 39, 52, and 60 (see Huang, 
this volume). Gene 39 has been cloned (Huang 1986a) and over-
produced in uninfected E. coli cells. It has a strong A TP-binding site and 
intrinsic prot~in kinase activity (W.M. Huang, unpubl.). The gp39 sub-
unit carries out an autophosphorylation reaction and also modifies gp52 
and gp60 of the T4 enzyme. gp52 has significant homology with gyrA 
(Huang 1986b), and the A and B subunits of DNA gyrase are substrates 
for modification by the T4 DNA topoisomerase gp39 protein kinase ac-
tivity. 
The T4 gp39 and E. coli gyrB protein have regions of distinct protein 
homology, and the B subunit of gyrase also has a kinase activity that is 
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weak by comparison with T4 gp39; gyrB protein undergoes an autophos-
phorylation reaction that is stimulated by Ca++ (W.M. Huang, unpubl.). 
The gyrB kinase activity also phosphorylates the gyrA subunit of E. coli 
gyrase. A major issue to be resolved is whether these protein kinase ac-
tivities exhibited by DNA topoisomerase II subunits are a manifestation 
of the intrinsic catalytic mechanism in which ATP is cleaved as DNA 
strand passage occurs or, alternatively, serve some regulatory role. 
C. Poly{ADP-ribosylatlon) of DNA Topoisomerases 
The poly(ADP-ribosylation) of DNA topoisomerases has been shown to 
occur efficiently in vitro (Ferro et al. 1983; 10ngstra-Bilen et al. 1983; 
Ferro and Olivera 1984; Darby et al. 1985). This modification is carried 
out by a nuclear enzyme, poly(ADP-ribose) synthetase, which has been 
extensively characterized in several eukaryotic systems (for reviews, see 
Hayaishi and Veda 1982; Ferro and Olivera 1987; Ueda i987). 
Nicotinamide-adenine dinucleotide (NAD) is the substrate for all ADP-
ribosylation reactions. The glycosidic bond between the nicotinamide 
ring and ribose (a high-energy bond) is cleaved, and the ADP-ribose 
moiety is transferred to the DNA topoisomerase target (probably to a car-
boxyl group of a glutamate side chain although this has not been directly 
established for DNA topoisomerases). The synthetase then continues 
transferring ADP-ribose residues to form ribose-ribose glycosidic 
linkages so that a chain of ADP-ribose monomer units (poly[ADP-
ribose]) is covalently attached to the DNA topoisomerase (see Fig. 1). 
An unusual property of the modifying enzyme in vivo is that the 
synthetase is quiescent without an activating DNA structure. Interrup-
tions in the DNA double helix, including double-strand breaks and 
single-strand nicks, are absolutely required to activate poly(ADP-ribose) 
synthetase. In the absence of activating DNA, the modification is quickly 
removed by another nuclear enzyme, poly(ADP-ribose) glycohydrolase. 
The human gene for poly(ADP-ribose) polymerase (huADPRP) has 
been cloned, sequenced, and mapped (Cherney et al. 1987; Kurosaki et 
al. 1987; Uchida et al. 1987). Human and mouse proteins are closely re-
lated evolutionarily, and domains for an NAD-binding site, an automodi-
fication segment, and a DNA-binding domain containing two "zinc fin-
gers" have been identified (Mazen et al. 1989). In a mouse, this gene is 
on chromosome 1, closely linked to the autoimmune locus gld 
(generalized lymphoproliferative disorder) (Huppi et al. 1989). 
In vitro, when DNA topoisomerase I from calf thymus is extensively 
modified by the homologous poly(ADPR-synthetase), DNA-relaxing ac-
tivity is abolished (Ferro et al. 1983; 10ngstra-Bilen et al.1983; Ferro and 
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Olivera 1984). DNA topoisomerase II can also be modified (Darby et al. 
1985). It has been suggested that poly(ADP-ribosylation) inhibits the 
DNA topoisomerase activity because the poly(ADP-ribose) chains 
decrease the affinity of topoisomerases for DNA. Since each ADP-ribose 
monomer has two negative charges, strong electrostatic repulsions exist 
between these moieties and the DNA substrate for topoisomerases (Ferro 
et al. 1984). Consistent with this electrostatic repulsion model (see Ferro 
and Olivera 1982; Zahradka and Ebisuzaki 1982; Ferro et al. 1984), the 
extent of modification that can be carried out by poly(ADPR-synthetase) 
in vitro depends on ionic strength. At low ionic strength, relatively mini-
mal levels of modification can be carried out before the enzyme can no 
longer bind DNA. As the ionic strength increases, much more extensive 
modification occurs (up to 40 ADP-ribose residues/protein). 
DNA topoisomerase I is one of the best exogenous acceptor proteins 
for ADPR-synthetase. Only a small subset of targets, including DNA 
topoisomerases, are efficiently modified under physiological conditions 
in vitro. The modification has also been detected in vivo (Krupitza and 
Cerutti 1989). The biological consequences of poly(ADP-ribose)-
synthetase-inhibition include a variety of effects on DNA repair and an 
elevation of the frequency of sister chromatid exchanges (Oikawa et al. 
1980). 
In the absence of any exogenous protein, the synthetase carries out an 
automodification reaction and becomes so extensively poly(ADP-ribo-
sylated) that it no longer binds DNA and therefore becomes inactive. 
However, exogenous targets such as DNA topoisomerase I depress 
automodification by competing with the synthetase as a substrate. The 
poly(ADP-ribosylation) of the synthetase itself may serve as a "timing 
device" so each enzyme molecule catalyzes poly(ADP-ribosylation) at a 
DNA strand break for a limited period of time before the enzyme self-
inactivates. 
II. PERSPECTIVES 
The experimental data described in this chapter suggest that the covalent 
modification of topoisomerases may playa regulatory role in vivo. DNA 
topoisomerases of higher eukaryotes are substrates for protein kinases 
and poly(ADPR-synthetase) in vitro and have been identified in the 
phosphorylated and ADP-ribosylated states in vivo. 
The report that Xenopus DNA topoisomerase I requires phosphoryla-
tion for enzymatic activity indicates that in some vertebrate systems, the 
degree of phosphorylation may be the critical factor determining the 
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amount of intracellular DNA topoisomerase activity. The question that 
needs to be addressed is how widespread is the requirement that DNA 
topoisomerases be phosphorylated in order to be active? Are the Xenopus 
results restricted to certain stages in the life cycle of vertebrates, or will 
this be a general feature of topoisomerases? The fact that yeast 
topoisomerase I can be cloned and expressed in E. coli in an active form 
(Bjomsti and Wang 1987) is indicative that this enzyme may be active 
without being phosphorylated. 
In contrast with the stimulatory effects of serine phosphorylation, 
tyrosine phosphorylation and poly(ADP-ribosylation) are potential me-
chanisms for inactivating topoisomerases. However, the tyrosine kinases 
that have been studied to date are not nuclear proteins, and therefore the 
in vivo significance of tyrosine modification remains problematic. In 
contrast, poly(ADP-ribose) synthetase is a ubiquitous nuclear enzyme in 
higher eukaryotes; the evidence that this modification has physiological 
relevance is more compelling. 
Phosphorylation and ADP-ribosylation are not specific to DNA 
topoisomerases; the best characterized enzymes relevant to DNA 
topoisomerase modification, casein kinase II and poly(ADP-ribose) 
synthetase, are known to modify a number of other proteins under 
physiological conditions. It seems likely that these enzymes are general 
triggers for changing the physiological state of the nucleus. The cellular 
function of these DNA topoisomerase modifications is best explored in 
the larger context of synthetase and casein kinase II physiology, and the 
entire spectrum of proteins modified needs to be considered. 
Casein kinase II may be involved in cellular growth control. The en-
zyme appears to be activated when cells are proliferating. In contrast, 
poly(ADP-ribosylation) may be a general nuclear response to un-
scheduled interruptions in the DNA double helix such as strand breaks 
due to DNA damage. When the synthetase becomes activated, the en-
zyme modifies a number of proteins involved in the chromatin structure 
including his tones and topoisomerases. 
Thus, changes in the chromatin structure and metabolism may take 
place in the vicinity of a DNA strand break as a consequence of 
chromosomal protein ADP-ribosylation. Since sister chromatid exchange 
increases when synthetase is inhibited in vivo, it was previously sug-
gested that poly(ADP-ribosylation) of topoisomerase may be part of a 
general mechanism of suppressing mitotic recombination events at DNA 
strand breaks. Such a mechanism would be important for long-lived mul-
ticellular organisms in order to decrease the probability that accumulated 
recessive mutations become homozygous. Clear evidence has been pub-
lished recently that the activity of topoisomerases directly affect the fre-
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quency of crossing-over events (Christman et al. 1988; Kim and Wang 
1989; Wallis et al. 1989). 
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